DB1113, CAS [[2769753-53-7]]

Produktübersicht

• Artikelname: DB1113, CAS [[2769753-53-7]]
• Artikelnummer: MCE-HY-148061
• Hersteller Artikelnummer: HY-148061
• Alternativnummer: MCE-HY-148061-5MG,MCE-HY-148061-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DB1113 (Example 24) is a bifunctional compound targeted protein degradation of kinases. DB1113 degrades ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2, and ULK1. DB1113 can be used for research of disease or disorder mediated by aberrant kinase activity[1].

Produkteigenschaften

• Molekulargewicht: 1144.31
• Reinheit: 99.86
• CAS Nummer: [2769753-53-7]
• Formel: C59H68F3N13O6S
• Target-Kategorie: Bcr-Abl,CDK,Cyclin G-associated Kinase (GAK),Ferroptosis,LIM Kinase (LIMK),MAP4K,MAPKAPK2 (MK2),PROTACs,Salt-inducible Kinase (SIK),ULK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound